A graphical assessment of the potential impact of losses to follow-up on the validity of study results

Statistics in Medicine

Volumn 16, Issue 17, 1997, Pages 1943-1954

  Matts, John P ^a,b   Launer, Cynthia A ^a   Nelson, Eileen T ^a   Miller, Carol ^a   Dain, Bradley ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; FOLLOW UP;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS; HUMANS; MODELS, STATISTICAL; PATIENT DROPOUTS; RESEARCH DESIGN; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 0030772783     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19970915)16:17<1943::AID-SIM631>3.0.CO;2-R     Document Type: Article

References (26)

1. Meinert, C. L. Clinical Trials: Design, Conduct, and Analysis, Oxford University Press, New York, 1986.
2. Friedman, L. M., Furberg, C. D. and DeMets, D. L. Fundamentals of Clinical Trials, 2nd edn, PSG, Littleton, MA, 1985.
3. Gail, M. H. 'Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials', Cancer Treatment Reports, 699, 1107-1112 (1985).
4. Britton, A., Murrary, D., Bulstrode, C., McPherson, K., and Denham, R. 'Loss to follow-up: does it matter?', Lancet, 345, 1511-1512 (1995).
5. Bhaskar, R., Reitman, D., Sacks, H. S., Smith, H. Jr. and Chalmers, T. C. 'Loss of patients in clinical trials that measure long term survival following myocardial infarction', Controlled Clinical Trials, 7, 134-148 (1986).
6. Brown, M. B. 'A test for the difference between two treatments in a continuous measure of outcome when there are dropouts', Controlled Clinical Trials, 13, 213-225 (1992).
7. Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsh, M. S., Murphy, R. L., Hardy, W. D., Soeiro, R., Fischl, M. A., Bartlett, J. G., Merigan, T. C., Hyslop, N. E., Richman, D. D., Valentine, F. T., Corey, L. and the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. 'Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter', New England Journal of Medicine, 322, 941-949 (1990).
8. Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Phair, J. P., Mitsuyasu, R. T., Fischl, M. A., Soeiro, R. for the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. 'The duration of zidovudine benefit in persons with asysmptomatic HIV infection: Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group', Journal of the American Medical Association, 272, 437-442 (1994).
9. Hamilton, J. D., Hartigan, P. M., Simberkoff, M. S., Day, P. L., Diamond, G. R., Dickinson, G. M., Drusano, G. L., Egorin, M. J., George, W. L., Gordin, F. M., Hawkes, C. A., Jensen, P. C., Klimas, N. G., Labriola, A. M., Lahart, C. J., O'Brein, W. A., Oster, C. N., Weinhold, K. J., Wray, N. P., Zolla-Pazner, S. B. and the Veterans Affairs Cooperative Study Group on AIDS Treatment. 'A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: Results of the Veterans Affairs Cooperative Study', New England Journal of Medicine, 326, 437-443 (1992).
10. Concorde Coordinating Committee. 'Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection', Lancet, 343, 871-881 (1994).
11. Powderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., van der Horst, C., Koletar, S. L., Eyster, M. E., Carey, J., Waskin, H., Hooten, T. M., Hyslop, N., Spector, S. A., Bozzette, S. A. for the NIAID AIDS Clinical Trials Group. 'A randomized trial comparing fluconazole with clotrimazole for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection', New England Journal of Medicine, 332, 700-705 (1995).
12. Perriëns, J. H., St. Louis, M. E., Mukadi, Y. B., Brown, C., Prignot, J., Pouthier, F., Portaels, F., Willame, J. C., Mandala, J. K., Kaboto, M., Ryder, R. W., Roscigno, G. and Piot, P. 'Pulmonary tuberculosis in HIV-infected patients in Zaire: A controlled trial of treatment for either 6 or 12 months', New England Journal of Medicine, 332, 779-784 (1995).
13. Scandinavian Simvastatin Survival Study Group. 'Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)', Lancet, 344, 1383-1389 (1994).
14. Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., Alaupovic, P., Hirsch, L. J. and the MARS Research Group. 'Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerosis Regression Study (MARS)', Annals of Internal Medicine, 119, 969-976 (1993).
15. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. 'Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina', New England Journal of Medicine, 311, 1333-1339 (1984).
16. Jacobson, J. A., Danforth, D. N., Cowan, K. H., d'Angelo, T., Steinberg, S. M., Pierce, L., Lippman, M. E., Lichter, A. S., Glatstein, E. and Okunieff, P. 'Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer', New England Journal of Medicine, 332, 907-911 (1995)
17. Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., Ederer, F. for the Minnesota Colon Cancer Control Study. 'Reducing mortality from colorectal cancer by screening for fecal occult blood', New England Journal of Medicine, 328, 1365-1371 (1993).
18. Chalmers, T. C., Smith, H. Jr., Blackburn, B., Silverman, B., Schroeder, B., Reitman, D. and Ambroz, A. 'A method for assessing the quality of a randomized control trial', Controlled Clinical Trials, 2, 31-49 (1981).
19. Costagliola, D. and Mary-Knause, M. 'Zidovudine in patients with HIV infection', Annals of Internal Medicine, 124, 372 (letter) (1996).
20. Meittinen, O. Theoretical Epidemiology, Wiley, New York, 1985.
21. Deyton, L., Carlyn, M., Hedderman, M., Maiatico, G., Hoth, D. and Fauci, A. 'A national community-based AIDS research program: The Community Programs for Clinical Research on AIDS', Seventh International Conference on AIDS, Florence, Italy (abstract), 1991.
22. Matts, J. P., Daniels, K., Gordin, F., Korvick, J. and Deyton, L. R. 'Simplifying large mate: An example from the Community Programs for Clinical Research on AIDS', Controlled Clinical Trials, 13, 408 (abstract) (1992).
23. Selwyn, P. A., Sckell, B. M., Alcabes, P., Friedland, G. H., Klein, R. S. and Schoenbaum, E. E. 'High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy', Journal of the American Medical Association, 268, 504-509 (1992).
24. Brosgart, C., Craig, C., Louis, T. A., Hillman, D., Costanzo, L., Timpone, J., Scott, J., Nunley, F., Stempien, M. J. for the CPCRA. 'Design and demographics in a multicenter trial of cytomegalovirus (CMV) prophylaxis in advanced HIV disease', Tenth International Conference on AIDS, Yokohama, Japan (abstract), 1994.
25. 3', 3rd Conference on Retroviruses and Opportunistic Infections, Washington DC (abstract) 1996.
26. Raboud, J. M., Montaner, J. S. G., Thorne, A., Singer, J., Schechter, M. T. and the Canadian HIV Trial Network A002 Study Group. 'Impact of missing data due to dropouts on estimates of the treatment effect in a randomized trial of antiretroviral therapy of HIV-infected individuals', Journal of Acquired Immune Deficiency and Human Retrovirology, 12, 46-55 (1996).